Package 0603-0213-21

Brand: magnesium oxide

Generic: magnesium oxide
NDC Package

Package Facts

Identity

Package NDC 0603-0213-21
Digits Only 0603021321
Product NDC 0603-0213
Description

100 TABLET in 1 BOTTLE (0603-0213-21)

Marketing

Marketing Status
Marketed Since 2020-11-10
Brand magnesium oxide
Generic magnesium oxide
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "02fea0ac-d5c7-47b6-bd7f-df4024e37d3c", "openfda": {"unii": ["3A3U0GI71G"], "rxcui": ["311430"], "spl_set_id": ["d5c123f8-1396-4d8c-96d3-e5ade96a6ef8"], "manufacturer_name": ["Endo USA"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (0603-0213-21)", "package_ndc": "0603-0213-21", "marketing_start_date": "20201110"}], "brand_name": "Magnesium Oxide", "product_id": "0603-0213_02fea0ac-d5c7-47b6-bd7f-df4024e37d3c", "dosage_form": "TABLET", "pharm_class": ["Calculi Dissolution Agent [EPC]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "0603-0213", "generic_name": "Magnesium Oxide", "labeler_name": "Endo USA", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Magnesium Oxide", "active_ingredients": [{"name": "MAGNESIUM OXIDE", "strength": "253 mg/1"}], "application_number": "M001", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20201110", "listing_expiration_date": "20261231"}